Literature DB >> 32367470

[Pain management in sickle cell disease].

T Rasche1, D Emmert1, H Seidel2, J Sellin1, R Conrad3, M Mücke4.   

Abstract

Sickle cell disease is associated with numerous symptoms and complications. Acute painful crisis is the most characteristic manifestation of the disease. In addition, many patients report chronic pain. As both acute and chronic pain severely diminish quality of life, adequate pain management is crucial. Recommendations for the treatment of acute painful crises are based on the World Health Organization analgesic ladder, which has been developed for cancer-related pain. Chronic pain can be treated with basic long-acting opioids and on-demand short-acting opioids. If patients show signs of neuropathic pain, administration of anticonvulsants, antidepressants or possibly ketamine should be considered.

Entities:  

Keywords:  Acute painful crisis; Analgesics, opioid, long-acting; Analgesics, opioid, short-acting; Chronic pain; Neuralgia

Mesh:

Substances:

Year:  2020        PMID: 32367470     DOI: 10.1007/s00482-020-00465-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  7 in total

1.  The epidemiology of sickle cell disease in Germany following recent large-scale immigration.

Authors:  Joachim B Kunz; Holger Cario; Regine Grosse; Andrea Jarisch; Stephan Lobitz; Andreas E Kulozik
Journal:  Pediatr Blood Cancer       Date:  2017-04-06       Impact factor: 3.167

2.  Magnesium for treating sickle cell disease.

Authors:  Nan Nitra Than; Htoo Htoo Kyaw Soe; Senthil K Palaniappan; Adinegara Bl Abas; Lucia De Franceschi
Journal:  Cochrane Database Syst Rev       Date:  2019-09-09

3.  [Dose-finding for treatment with a transdermal fentanyl patch : Titration with oral transmucosal fentanyl citrate and morphine sulfate].

Authors:  M Mücke; R Conrad; M Marinova; H Cuhls; F Elsner; R Rolke; L Radbruch
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

Review 4.  Inhaled nitric oxide for treating pain crises in people with sickle cell disease.

Authors:  Tarek Aboursheid; Omar Albaroudi; Fares Alahdab
Journal:  Cochrane Database Syst Rev       Date:  2019-10-11

5.  Interventions for treating neuropathic pain in people with sickle cell disease.

Authors:  Monika R Asnani; Damian K Francis; Amanda M Brandow; Christine Eo Hammond Gabbadon; Amza Ali
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

Review 6.  Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger?

Authors:  Saranya Veluswamy; Payal Shah; Christopher C Denton; Patjanaporn Chalacheva; Michael C K Khoo; Thomas D Coates
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241

7.  Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.

Authors:  Tess E Cooper; Ian R Hambleton; Samir K Ballas; Brydee A Johnston; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2019-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.